-
Nicotine Signaling in Chronic Kidney Disease Progression
2026-08-22
The review by Jain and Jaimes integrates clinical observations with animal and mechanistic evidence to explain how nicotine may accelerate chronic kidney disease through renal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and fibrosis. Its main contribution is to distinguish nicotine-mediated biology from the broader chemical complexity of cigarette smoke, while identifying experimental pathways that may be relevant to CKD research.
-
α-Amanitin Workflows for Transcription Studies
2026-08-22
Use α-Amanitin as a mechanistic RNA polymerase II perturbant, not merely a cytotoxic reagent. This guide connects transcription assays with mitochondrial and developmental readouts, offering practical workflows, controls, and troubleshooting strategies for interpretable results.
-
Ibrexafungerp: From pH Assay to VVC Translation
2026-08-21
Ibrexafungerp (MK 3118) combines oral delivery with a distinct glucan synthase mechanism and preserved activity under acidic vaginal conditions. This article translates pH-aware susceptibility testing into practical VVC, resistance, and preclinical model decisions.
-
L1023 Anti-Cancer Compound Library Workflow
2026-08-20
Build a reproducible phenotypic-to-mechanistic screen with 1,164 pre-dissolved compounds spanning kinase, proteasome, HDAC, deubiquitinase, and other oncology-relevant targets. This workflow shows how to connect plate-based viability data with pathway biomarkers, resistance profiling, and the latest structural insight into STING activation.
-
Protein A/G Beads for IVDD Mechanism Translation
2026-08-20
A translational strategy for using Protein A/G Magnetic Beads to validate the MAPK1/HMOX1–mitophagy–pyroptosis axis identified in intervertebral disc degeneration research, while separating discovery signals from causal evidence.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-19
Use one transcript to distinguish mRNA delivery from productive protein expression: Cy5 reveals where cargo travels, while Firefly Luciferase reports translation. This guide applies the platform to transfection optimization, intracellular trafficking, formulation screening, and in vivo bioluminescence imaging with practical controls and troubleshooting.
-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-08-19
The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links protein O-GlcNAc modification to iron handling, ferroptosis, and trophoblast syncytialization in preeclampsia. Its integrated proteomic, cellular, placental, and mouse evidence suggests that stabilizing O-GlcNAcylated HUWE1 promotes TfR1 ubiquitination and limits iron-driven trophoblast injury.
-
A-1210477: MCL-1 Inhibitor Workflow
2026-08-18
A-1210477 enables a focused test of whether cancer cells depend on MCL-1-mediated protection from mitochondrial apoptosis. This practical workflow combines controlled dosing, BAX/BAK-aware validation, orthogonal apoptosis readouts, and navitoclax combination testing while accounting for solubility and in vivo pharmacokinetic limitations.
-
DiI (DiIC18(3)) Membrane Probe Guide
2026-08-18
DiI (DiIC18(3)), SKU B8804, provides orange-red labeling of lipid membranes for live or fixed cell and tissue workflows, including neuronal tracing, migration, adhesion, and lipoprotein-associated studies. It should be prepared in an organic solvent rather than water and should not be treated as an intracellular organelle or cytoplasmic marker.
-
Caffeine Workflows for Cancer and Metabolic Research
2026-08-17
Build reproducible Caffeine assays across cancer cell line inhibition, VPA combination studies, and diet-induced obesity mouse model readouts. This guide separates evidence-backed findings from practical starting conditions and uses a recent ALDH2 activator study to sharpen control design without overstating what Caffeine can prove.
-
Carvedilol: From Cardiac Signaling to Marrow Recovery
2026-08-17
A translational perspective on how Carvedilol’s dual adrenergic activity and antioxidant profile can inform cardiovascular, vascular, and hematopoietic research—while highlighting the experimental and clinical implications of nonselective β-blockade after hematopoietic cell transplantation.
-
Merbromin Workflows for Fluorescence and Tissue Studies
2026-08-16
Merbromin is a versatile biochemical research fluorescent dye that connects quantitative protein-binding analysis with exploratory antimicrobial, antiviral, and tissue-visibility workflows. This guide separates literature-backed findings from practical starting conditions so researchers can optimize assays without treating a research reagent as a validated clinical stain or therapeutic.
-
Ginsenoside Rg1: From Molecule to Axis
2026-08-15
Ginsenoside Rg1 is a triterpene saponin whose research value extends beyond isolated neuronal assays. This article explains how to connect chemical handling, Treg-dependent gut–immune–brain measurements, and causal interpretation in neuroprotection research.
-
AEBSF.HCl: Protease Inhibition Workflows
2026-08-14
AEBSF.HCl provides irreversible, broad-spectrum serine protease control for cell lysis, APP-processing, amyloid-beta, and protease-dependent cell-death assays. This practical guide shows how to integrate it with lysosomal membrane permeabilization and necroptosis workflows while avoiding misinterpretation of cathepsin-driven effects.
-
MK-5108: Aurora A Workflow for Cancer Research
2026-08-14
MK-5108 (VX-689) combines exceptional Aurora-A potency with a practical workflow for cell-cycle, proliferation, and xenograft studies. Its use becomes especially informative when pharmacologic inhibition is paired with AURKA expression, RB1 status, or MYCN-associated tumor biology.